214 related articles for article (PubMed ID: 9277585)
41. Angiotensin II type 1 receptor-mediated augmentation of renal interstitial fluid angiotensin II in angiotensin II-induced hypertension.
Nishiyama A; Seth DM; Navar LG
J Hypertens; 2003 Oct; 21(10):1897-903. PubMed ID: 14508196
[TBL] [Abstract][Full Text] [Related]
42. Kidney Response to Chemotherapy-Induced Heart Failure: mRNA Analysis in Normotensive and
Jíchová Š; Gawryś O; Kompanowska-Jezierska E; Sadowski J; Melenovský V; Hošková L; Červenka L; Kala P; Veselka J; Čertíková Chábová V
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445179
[TBL] [Abstract][Full Text] [Related]
43. Hypotensive function of the brain angiotensin-(1-7) in Sprague Dawley and renin transgenic rats.
Dobruch J; Paczwa P; Łoń S; Khosla MC; Szczepańska-Sadowska E
J Physiol Pharmacol; 2003 Sep; 54(3):371-81. PubMed ID: 14566076
[TBL] [Abstract][Full Text] [Related]
44. Enhanced tubuloglomerular feedback in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension.
Mitchell KD; Mullins JJ
Am J Physiol Renal Physiol; 2005 Dec; 289(6):F1210-6. PubMed ID: 16033920
[TBL] [Abstract][Full Text] [Related]
45. Epoxyeicosatrienoic Acid-Based Therapy Attenuates the Progression of Postischemic Heart Failure in Normotensive Sprague-Dawley but Not in Hypertensive
Hrdlička J; Neckář J; Papoušek F; Husková Z; Kikerlová S; Vaňourková Z; Vernerová Z; Akat F; Vašinová J; Hammock BD; Hwang SH; Imig JD; Falck JR; Červenka L; Kolář F
Front Pharmacol; 2019; 10():159. PubMed ID: 30881303
[TBL] [Abstract][Full Text] [Related]
46. Adrenal, kidney, and heart angiotensins in female murine Ren-2 transfected hypertensive rats.
Senanayake PS; Smeby RR; Martins AS; Moriguchi A; Kumagai H; Ganten D; Brosnihan KB
Peptides; 1998; 19(10):1685-94. PubMed ID: 9880073
[TBL] [Abstract][Full Text] [Related]
47. Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats.
Senanayake PD; Moriguchi A; Kumagai H; Ganten D; Ferrario CM; Brosnihan KB
Peptides; 1994; 15(5):919-26. PubMed ID: 7984514
[TBL] [Abstract][Full Text] [Related]
48. Effects of chronic cytochrome P-450 inhibition on the course of hypertension and end-organ damage in Ren-2 transgenic rats.
Chábová VC; Kramer HJ; Vanecková I; Vernerová Z; Eis V; Tesar V; Skaroupková P; Thumová M; Schejbalová S; Husková Z; Vanourková Z; Kolský A; Imig JD; Cervenka L
Vascul Pharmacol; 2007; 47(2-3):145-59. PubMed ID: 17604232
[TBL] [Abstract][Full Text] [Related]
49. Effects of captopril, losartan, and nifedipine on cell hypertrophy of cultured vascular smooth muscle from hypertensive Ren-2 transgenic rats.
Peiró C; Llergo JL; Angulo J; López-Novoa JM; Rodríguez-López A; Rodríguez-Mañas L; Sánchez-Ferrer CF
Br J Pharmacol; 1997 Aug; 121(7):1438-44. PubMed ID: 9257925
[TBL] [Abstract][Full Text] [Related]
50. The renin-angiotensin system and renal function in transgenic (mRen2)27 rats.
Gross V; Lippoldt A; Bohlender J; Ganten D; Ganten U; Luft FC
Exp Nephrol; 1996; 4 Suppl 1():20-6. PubMed ID: 9001893
[TBL] [Abstract][Full Text] [Related]
51. Increased bradykinin and "normal" angiotensin peptide levels in diabetic Sprague-Dawley and transgenic (mRen-2)27 rats.
Campbell DJ; Kelly DJ; Wilkinson-Berka JL; Cooper ME; Skinner SL
Kidney Int; 1999 Jul; 56(1):211-21. PubMed ID: 10411695
[TBL] [Abstract][Full Text] [Related]
52. Role of tissue renin in the pathophysiology of hypertension in TGR(mREN2)27 rats.
Bader M; Zhao Y; Sander M; Lee MA; Bachmann J; Böhm M; Djavidani B; Peters J; Mullins JJ; Ganten D
Hypertension; 1992 Jun; 19(6 Pt 2):681-6. PubMed ID: 1592468
[TBL] [Abstract][Full Text] [Related]
53. AT1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension.
Kobori H; Prieto-Carrasquero MC; Ozawa Y; Navar LG
Hypertension; 2004 May; 43(5):1126-32. PubMed ID: 15037565
[TBL] [Abstract][Full Text] [Related]
54. Estrogen protects transgenic hypertensive rats by shifting the vasoconstrictor-vasodilator balance of RAS.
Brosnihan KB; Li P; Ganten D; Ferrario CM
Am J Physiol; 1997 Dec; 273(6):R1908-15. PubMed ID: 9435644
[TBL] [Abstract][Full Text] [Related]
55. Circadian rhythms in renal function in hypertensive TGR(mRen-2)27 rats and their normotensive controls.
Pons M; Schnecko A; Witte K; Lemmer B; Waterhouse JM; Cambar J
Am J Physiol; 1996 Oct; 271(4 Pt 2):R1002-8. PubMed ID: 8897993
[TBL] [Abstract][Full Text] [Related]
56. Intrarenal AT(1) receptor and ACE binding in ANG II-induced hypertensive rats.
Harrison-Bernard LM; Zhuo J; Kobori H; Ohishi M; Navar LG
Am J Physiol Renal Physiol; 2002 Jan; 282(1):F19-25. PubMed ID: 11739108
[TBL] [Abstract][Full Text] [Related]
57. Role of the circulating renin-angiotensin system in the pathogenesis of hypertension in transgenic rats. TGR(mREN2)27.
Peters J; Hilgers KF; Maser-Gluth C; Kreutz R
Clin Exp Hypertens; 1996 Oct; 18(7):933-48. PubMed ID: 8886477
[TBL] [Abstract][Full Text] [Related]
58. Endothelin receptor blockade does not affect blood pressure or angiotensin II levels in CYP1A1-Ren-2 transgenic rats with acutely induced hypertension.
Vanourková Z; Kramer HJ; Erbanová M; Bäcker A; Cervenka L; Husková Z; Chábová VC; Tesar V; Dvorák P; Malý J; Vanecková I
Vascul Pharmacol; 2009; 50(5-6):194-9. PubMed ID: 19563737
[TBL] [Abstract][Full Text] [Related]
59. Effects of sodium restriction and cyclooxygenase-2 inhibition on the course of hypertension, proteinuria and cardiac hypertrophy in Ren-2 transgenic rats.
Vanecková I; Skaroupková P; Dvorák P; Certíková Chábová V; Tesar V; Bader M; Ganten D; Kramer HJ
Physiol Res; 2005; 54(1):17-24. PubMed ID: 15717837
[TBL] [Abstract][Full Text] [Related]
60. [Effect of a non-antihypertensive dose of ramipril on the plasma and tissue renin-angiotensin system in 27 TGR (mRen2) rats].
Grima M; Anjuère J; Ingert C; Coquard C; Steger J; Barthelmebs M; Imbs JL
Arch Mal Coeur Vaiss; 2001 Aug; 94(8):805-12. PubMed ID: 11575208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
